Cargando…
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
Non-invasive biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are urgently needed. Such biomarkers can improve the safety of analytic treatment interruption (ATI) and provide mechanistic insights into the host pathways involved in post-ART HIV control. Here we re...
Autores principales: | Giron, Leila B., Palmer, Clovis S., Liu, Qin, Yin, Xiangfan, Papasavvas, Emmanouil, Sharaf, Radwa, Etemad, Behzad, Damra, Mohammad, Goldman, Aaron R., Tang, Hsin-Yao, Johnston, Rowena, Mounzer, Karam, Kostman, Jay R., Tebas, Pablo, Landay, Alan, Montaner, Luis J., Jacobson, Jeffrey M., Li, Jonathan Z., Abdel-Mohsen, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241829/ https://www.ncbi.nlm.nih.gov/pubmed/34188039 http://dx.doi.org/10.1038/s41467-021-24077-w |
Ejemplares similares
-
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
por: Giron, Leila B., et al.
Publicado: (2021) -
Interferon-α alters host glycosylation machinery during treated HIV infection
por: Giron, Leila B., et al.
Publicado: (2020) -
A Correlate of HIV-1 Control Consisting of Both Innate and Adaptive Immune Parameters Best Predicts Viral Load by Multivariable Analysis in HIV-1 Infected Viremic Controllers and Chronically-Infected Non-Controllers
por: Tomescu, Costin, et al.
Publicado: (2014) -
Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
por: Papasavvas, Emmanouil, et al.
Publicado: (2004) -
Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients
por: Giron, Leila B., et al.
Publicado: (2021)